A 39-year-old unvaccinated Franklin County woman has died after a recent measles diagnosis. Nationally, numbers continue to increase and the US has passed 4,000 cases.
|Articles|June 10, 2020
Contagion Live News Network: Stenotrophomonas Clonal Group Shows Increased Biofilm Capacity
Author(s)Contagion® Editorial Staff
A summary of the latest infectious disease news.
Advertisement
Hello and welcome to Contagion. I’m assistant editor Grant Gallagher here with a brief on our top stories.
Stenotrophomonas maltophilia acquisition can lead to difficult respiratory issues for the immunocompromised. The multidrug-resistant opportunistic infection has increased in incidence within health care and community settings alike.
A team of European researchers have identified links between antibiotic resistant S maltophilia phenotypes and quorum sensing, a gene-regulation process which the bacterium can use to coordinate adaptations to host-cell environment. Results were published in
In other news, ImmunityBio continues to advance its Operation Warp Speed vaccine candidate in the hunt for a protective measure against SARS-CoV-2.
In an
Lastly, we featured an article from our print issue, providing pharmacist perspectives on Lefamulin. For these stories, and more infectious disease clinical coverage, visit Contagionlive.com. Thanks for listening.
Advertisement
Related to this article
The National Foundation for Infectious Diseases (NFID) recently held its respiratory season kick-off, which included the release of its annual respiratory disease survey. This year, the survey revealed the gap between vaccine support and uptake. Robert Hopkins Jr, MD, medical director of NFID delves deeper into the findings of the survey and the vaccine uptake challenges associated with certain immunizations.
The latest CDC numbers show a 5.0% increase of measles cases from week-to-week. The US total reached 4080 confirmed cases, 78% above all of 2025.
With US measles cases nearing 3,900 this year and Pennsylvania reporting its fifth measles-related death, here is a review of how the virus spreads, how it is prevented and managed, and what severe disease looks like.
Vaxcyte's 31-valent pneumococcal conjugate vaccine candidate met every prespecified primary immunogenicity and safety endpoint against PCV20 and PCV21 in the OPUS-1 trial of 4,047 US adults.
Irkutsk anti-plague institute death prompts quarantines and conflicting official accounts.
A laboratory technician at a Siberian anti-plague institute has died of pneumonia of unknown cause, prompting quarantines and contact monitoring while Russian officials stop short of confirming plague.
A study finding clesrovimab comparable to palivizumab in protecting at-risk infants in their first RSV season was extended to demonstrate clesrovimab effective and well-tolerated when administered in their second season.
Advertisement
Advertisement